HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Induction of tumors with cycasin in newborn and preweanling rats.

Abstract
Comprehensive studies of carcinogenesis in newborn or preweanling SD rats were conducted under various dose schedules of cycasin (CAS: 14901-08-7) administration. When cycasin was given sc to newborn rats at day 0, tumors were detected in more than 80% of rats of both sexes; kidney tumors were by far the most common. The incidences of tumors declined in the older groups, namely, over 60% in both sexes in the 7-day group, 55% in males and 8.3% in females in 14-day rats, and 0% in 21-day groups. By multiple administration, tumor incidences elevated considerably. Administration ip of cycasin also gave rise to tumor induction in newborn rats. A total of 435 kidney tumors found in the experiments were studied pathologically. Most of them were classified as mesenchymal tumor; some of them metastasized. A few other tumors were found in the liver and colon.
AuthorsR Fukunishi, A Kadota, A Yoshida, N Hirota
JournalJournal of the National Cancer Institute (J Natl Cancer Inst) Vol. 74 Issue 6 Pg. 1275-81 (Jun 1985) ISSN: 0027-8874 [Print] United States
PMID2987594 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Azo Compounds
  • Cycasin
Topics
  • Adenocarcinoma (chemically induced, pathology)
  • Animals
  • Animals, Newborn
  • Animals, Suckling
  • Azo Compounds
  • Carcinoma, Hepatocellular (chemically induced, pathology)
  • Colonic Neoplasms (chemically induced, pathology)
  • Cycasin
  • Female
  • Kidney Neoplasms (chemically induced, pathology)
  • Liver Neoplasms (chemically induced, pathology)
  • Male
  • Mesenchymoma (chemically induced, pathology)
  • Neoplasms, Experimental (chemically induced, pathology)
  • Rats
  • Rats, Inbred Strains

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: